A Randomized, Double-Blind, Comparative Study of Azithromycin Versus Clarithromycin in Combination With Ethambutol for the Treatment of Disseminated Mycobacterium Avium Complex (MAC) Infection in AIDs Patients - Related Studies

A Randomized, Double-Blind, Comparative Study of Azithromycin Versus Clarithromycin in Combination With Ethambutol for the Treatment of Disseminated Mycobacterium Avium Complex (MAC) Infection in AIDs Patients

This study has been completed.

Study NCT00002140. Last updated on June 23, 2005. Information provided by NIH AIDS Clinical Trials Information Service

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		HIV Infections

2	Additional conditions recognized in this trial
		Acquired Immunodeficiency Syndrome
		Communicable Diseases
		Infection
		Mycobacterium avium-intracellulare Infection
		Mycobacterium Infections

3	More general conditions related to this trial
		Actinomycetales Infections
		Bacterial Infections
		Gram-Positive Bacterial Infections
		Immune System Diseases
		Immunologic Deficiency Syndromes
		Lentivirus Infections
		Mycobacterium Infections, Atypical
		Retroviridae Infections
		RNA Virus Infections
		Sexually Transmitted Diseases
		Sexually Transmitted Diseases, Viral
		Slow Virus Diseases
		Virus Diseases

4	Interventions listed in this trial
		Ethambutol hydrochloride
		Clarithromycin
		Azithromycin

5	Additional drug interventions recognized in this trial
		Ethambutol

6	More general drug interventions related to this trial
		Anti-Bacterial Agents
		Anti-Infective Agents
		Antitubercular Agents
		Enzyme Inhibitors
		Molecular Mechanisms of Pharmacological Action
		Pharmacologic Actions
		Protein Synthesis Inhibitors
		Therapeutic Uses

7	Sponsors listed in this trial
		Pfizer